NCT05460780View on ClinicalTrials.gov

First-in-human, Study of MATTISSE® Tissue Engineering Chamber in Adult Female Patients Undergoing Breast Reconstruction After Mastectomy for Cancer

NARecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

July 1, 2022

Primary Completion Date

July 31, 2027

Study Completion Date

December 31, 2028

Conditions
Breast Cancer FemaleBreast Cancer PreventBreast Reconstruction
Interventions
DEVICE

MATTISSE TEC

Tissue engineering chamber MATTISSE

Trial Locations (3)

59000

RECRUITING

Hospital of Lille, Lille

67091

RECRUITING

CHU de Strasbourg, Strasbourg

0159

RECRUITING

Institute of Clinical Oncology, Tbilisi

Sponsors

Collaborators (1)

Lattice Medical
All Listed Sponsors
collaborator

Lattice Medical

UNKNOWN

lead

Quanta Medical

INDUSTRY

NCT05460780 - First-in-human, Study of MATTISSE® Tissue Engineering Chamber in Adult Female Patients Undergoing Breast Reconstruction After Mastectomy for Cancer | Biotech Hunter | Biotech Hunter